Healthy volunteers test new Drug's safety in early trial
NCT ID NCT07141199
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 32 times
Summary
This early-stage study tested the safety and tolerability of a new drug called ABBV-8736 in 24 healthy adult volunteers. Participants received multiple doses of the drug or a placebo to see how the body processes it and whether it causes side effects. The goal was not to treat any disease, but to gather important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Acpru /Id# 277377
Grayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.